Certified clevidipine butyrate products-the novel-class
ingredient for clevidipine butyrate injection under the
tradename of Cysolvia®. Our powerful sales and technical
teams are famous for agile market insights and strong
awareness of issues, always capable of solving various
problems from customers’ perspectives.

Certified felodipine products-the innovative-class
ingredient for felodipine oral tablets under the tradename
of Cysolvia®. We support the tailored formula design, specifications adjustment and technical improvement
to meet our partners complicated business demands.

Certified cilnidipine and its intermediate products-the
purest ingredient for cilnidipine oral tablets under the
tradename of Cysolvia®. We think highly of the stability in
every aspects so we adopt the branding strategy to
assure our customers with products’ quality and
integrated services.

Certified manidipine dihydrochloride product-the purest
raw material for manidipine oral tablets under the
tradename of Cysolvia®. We are devoted to providing
more innovative hypotensive solutions for the
pharmaceutical industry and clinical therapies.

Qualified nisoldipine product as the essential raw material
for nisoldipine oral tablets under the tradename of
Cysolvia®. Having the property of the treatment of high
blood pressure it is a pivotal component in the final
hypotensive drugs with a longer functioning time and
better effect.

One of dihydropyridine-type calcium channel blockers
(CCBs) critically composes the final nitrendipine
hypotensive drugs that can moderately lower the blood
pressure. Its time to peak is about 1.5 hours, time of
duration 6-8 hours and half-life lasts 2 hours.

A critical element in crafting the final hypotensive drugs of
dihydropyridine-class calcium channel blockers (CCBs). It
has the property of rapid oral absorption and the
treatment of ischemic lesion of brain tissue due to
cerebral vasospasm caused by subarachnoid hemorrhage.

The nicardipine in the form of hydrochloride salt,
synthetically deriving from nitrophenyl-pyridine and acting
as a potent calcium channel blocker (CCB). It is a pivotal
element in crafting small molecule drugs with better
antihypertensive and anti-angina properties.

The active element of nifedipine hypotensive drugs which
are also named as BAY a 1040, the first generation
dihydropyridine calcium channel blocker (CCB) indicated
for the management of several subtypes of angina
pectoris, and hypertension. It is potent and takes effect
rapidly.